menu
    • menu

    Company profile for Zhejiang Huahai Pharmaceutical

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry...
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Zhejiang Huahai PharmaceuticalChina Flag
    Country
    Country
    China
    Address
    Address
    Xunqiao, Linhai, Zhejiang 317024
    Telephone
    Telephone
    +86-576-85016116
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://en.huahaipharm.com:443/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    CPhI India 2024

    CPhI India 2024

    Not Confirmed

    envelop Contact Supplier

    CPhI India 2024

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    “LGM Pharma has made significant strides in meeting the evolving needs of its clients”

    “LGM Pharma has made significant strides in meeting the evolving needs of its clients”

    This week, SpeakPharma interviews four senior executives of LGM Pharma — Shailesh Vengurlekar (Senior VP, Quality and Regulatory Affairs), Deepak Thassu (Senior VP, R&D and Regulatory Submission), Selwyn Lustman (Senior VP, Global Sourcing and Procurement), and Mike Stenberg (VP, Business Development). The four VPs talk about expansion in manufacturing capabilities of the Florida-based contract development and manufacturing organization (CDMO), expertise that makes LGM a strong partner and the criteria it adopts while selecting its suppliers.  HIGHLIGHTS// expansion in manufacturing capabilities/ expertise that makes LGM a strong partner/ criteria for selecting its suppliers LGM Pharma recently invested heavily in expanding its CDMO capabilities by 50 percent. Can you share why offering standalone analytical testing services is important to LGM Pharma’s growth strategy? How does it benefit your clients? Vengurlekar: This recent expansion in CDMO capabilities is part of LGM Pharma’s growth strategy that lays importance on diversification. One key area of this diversification is the offering of standalone Analytical Testing Services (ATS). This service plays a crucial role in supporting our clients by providing them with greater flexibility and reliability. LGM Pharma is already a well-established leader in the API supply chain. We have now identified a significant need in the market and are now serving compounding pharmacies, including 503A and 503B facilities. These pharmacies not only require high-quality, GMP-compliant APIs, but also need a trusted, compliant, and capable laboratory to analyze both their APIs and compounded products. Recognizing this opportunity to further support our clients, LGM Pharma has expanded into ATS. We have witnessed tremendous growth since we’ve launched these services. By offering ATS under a separate legal entity — LGM Pharma Solutions — we are able to provide an additional layer of flexibility to our clients. This structure eliminates any conflict of interest. While LGM Pharma LLC handles API supply, LGM Pharma Solutions focuses on delivering top-tier ATS, all under the same LGM Pharma umbrella. This setup enhances trust and allows our clients to work with us more seamlessly. HIGHLIGHTS// diversified into standalone ATS/ well-established leader in API supply chain/ serving compounding pharmacies/ offering APIs and ATS under different legal entities. While suppositories offer clear advantages for certain medications, can you describe how LGM Pharma plans to leverage its expertise in this area to address specific unmet needs in the growing women’s health market? Thassu: We’re taking a dual approach to enhance both our R&D and manufacturing capabilities. First, we’ve introduced a new semi-automatic machine that allows us to produce smaller batches more efficiently. This is particularly important for the suppository segment, where demand doesn’t require large-scale production. The new system enables quicker adjustments to the manufacturing process, providing us with greater flexibility of producing small batches. Second, many of the materials we handle in the women’s health sector are sensitive to heat, light, and oxygen. To address this, we’re upgrading our facility to accommodate these specialized requirements. This ensures we can develop and manufacture products while maintaining the integrity of heat-, light-, and oxygen-sensitive ingredients. Additionally, we’re working closely with clients to prepare for various technical challenges. Whether it’s processing homeopathic ingredients or handling delicate fermentation-based materials, which are highly sensitive to both light and heat, our team has upgraded its skills and equipment to manage these complexities. From technology advancements in manufacturing to specialized handling conditions and improved technical expertise, we’ve made significant strides to ensure we can meet the evolving needs of our clients and their products. HIGHLIGHTS// dual approach to enhance R&D and manufacturing capabilities/ upgrading facilities to accommodate specialized requirements/ working with clients to address challenges. The pandemic underscored supply chain problems. Can you detail the specific criteria LGM Pharma uses while selecting suppliers for its manufacturing processes? Lustman: LGM looks at many facets of a manufacturer before proceeding to approve them for a specific project. We start by checking their regulatory history with the US Food and Drug Administration (FDA) and other authorities. We try to find out if they have received any warning letters. What is their inspection history? Have they received NAIs (no action indicated) and VAIs (voluntary action indicated)? We further investigate the company’s overall business status — we need to know that they are a stable partner to work with in the long term. Manufacturers are then assessed for their overall technology and the number of employees working in various fields, such as R&D, quality control, quality assurance, regulatory affairs, manufacturing, and the educational levels of these employees. Once we have established that the manufacturer is a potential partner, we check their status for a particular project. We look at their advantages, and whether they have a non-infringing route of synthesis (ROS) that will allow early launch. Are they developing a second process that will be more competitive in pricing? And, does the manufacturer have the necessary capacity and/or spare capacity for the project that we are assessing? We need to know whether the drug master file (DMF) has been registered, the current batch size, and the potential for increase in batch size. Pricing is a key indicator — we need to know whether the pricing of the manufacturer is competitive or not, and if the manufacturer will be able to compete in the future as the project matures. LGM always assesses for quality, price, and delivery. Goods must be of the correct quality, at the right price, with delivery time as desired, in order to meet commercial needs. HIGHLIGHTS// investigate various facets of manufacturer before approving them for a project/ look at advantages, non-infringing ROS/ assess for quality, price, delivery Can you highlight specific capabilities and experiences LGM Pharma possesses that make it a strong partner for companies developing antibody-drug-conjugates (ADCs)? Stenberg: ADCs are often peptides linked with small molecules. However, they may also be peptides linked with oligonucleotides. Regardless, LGM can help manage the supply chain associated with the components that are used in the conjugation of the ADC. LGM has extensive experience, and an extensive network around sourcing and managing the supply chain associated with ADC components. LGM’s experience and capabilities extend to sourcing peptides, small molecules or oligonucleotides used in the conjugation process. Additionally, given our deep relationships in the supply chain aspect of this process, LGM may also be able to identify partners who can help with the conjugation process itself. HIGHLIGHTS// extensive experience, network around sourcing, managing supply chain associated with ADC components / identify partners that can help with conjugation process

    Impressions: 1131

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/lgm-pharma-has-made-significant-strides-in-meeting-the-evolving-needs-of-its-clients

    #SpeakPharma With LGM Pharma
    09 Nov 2024
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    Chinese FDA-registered generic facilities gain steam, India maintains lead with 396 facilities

    Chinese FDA-registered generic facilities gain steam, India maintains lead with 396 facilities

    Every year, the US Food and Drug Administration (FDA) publishes the user fee amounts it will collect from manufacturers of pharmaceuticals, generic drugs, biosimilars and medical devices in the coming financial year. The fee for fiscal year 2025 under the Generic Drug User Fee Act (GDUFA) was published on July 31, 2024.The GDUFA, established in 2012, authorizes FDA to assess and collect fees from drug manufacturers to expedite the delivery of safe, high-quality, and affordable generic drugs to the American public.The FDA’s facility payments list under GDUFA reveals that as of November 14, 2024, 1,397 facilities had paid their registration fees for financial year 2025. Of these facilities, 707 or 50.6 percent are active pharmaceutical ingredients (API) facilities, 405 or 29 percent are finished dosage forms (FDF) facilities, 69 (4.9 percent) are facilities that produce both APIs and FDFs, and 216 (15.5 percent) are contract manufacturing services (CMO) sites.Teva Pharmaceuticals, with 29 facility registrations, led the list of companies, followed by Aurobindo Pharma, Sun Pharma, and Dr. Reddy's Laboratories. Fiscal year Facility Registrations 2016 1,425 2017 1,442 2018 1,269 2019 1,286 2020 1,300 2021 1,340 2022 1,385 2023 1,394 2024 1,447 2025 1,397  Generic Drug Facilities Registered with the US FDA for FY2025 (Free Excel Available)India continues to lead with 396 facilities, US and China follow India maintains its dominance in total facility registrations with the FDA, registering 396 facilities for FY2025. This includes 214 API facilities, 135 FDF facilities, 21 facilities engaged in both API and FDF activities, and 26 CMO facilities.The United States holds the second position with 328 facilities, while China strengthened its third position with 197 facilities.With 214 API facilities, India continues to have the largest share of API manufacturing sites, outmatching the combined total of China (128) and the US (83), which together account for 211 facilities. Among European manufacturers, Italy leads with 59 API manufacturing sites, followed by Spain (30) and Germany (25).The US has maintained its lead in FDF facilities with 143 sites, followed closely by India with 135 sites and China with 45 sites. Country API FDF Both CMO Total India 214 135 21 26 396 US 83 143 13 89 328 China 128 45 12 12 197 Italy 59 3 2 19 83 Germany 25 4 1 15 45 Spain 30 9 1 4 44 Canada 7 17   13 37 Taiwan 9 6 5 4 24 Switzerland 15 4   4 23 France 16     6 22 Japan 18   1   19 United Kingdom 12 1   2 15 Mexico 9 1   1 11 Ireland 5 5   1 11   Generic Drug Facilities Registered with the US FDA for FY2025 (Free Excel Available) GDUFA III user fee rates increase across categories for FY25The GDUFA, which was reauthorized on September 30, 2022 (as GDUFA III), continues with provisions that will last until September 30, 2027. In July 2024, the FDA published updated user fee rates for FY2025.The facility fees have seen increases across all categories. API facility fees increased by 3 percent for domestic sites (to US$ 41,580) and 2 percent for foreign sites (to US$ 56,580). FDF facility fees rose by 5 percent for both domestic (to US$ 231,952) and foreign sites (to US$ 246,952). CMO facility fees increased by 5 percent for domestic sites (to US$ 55,668) and 4 percent for foreign sites (to US$ 70,668).Additionally, the fee for large-, medium- and small-sized drug applicants has increased by over 9 percent, compared to the 7 percent increase seen in 2023. Generic Drug Facilities Registered with the US FDA for FY2025 (Free Excel Available) China leads new facility registrations as FDA records 41 new units in FY25Out of the total 1,397 facilities registered for FY2025, 41 were new registrations (going by Facility FDA Establishment Identifier numbers). China led the way with 13 new facilities, followed closely by India with 11 new facilities, while the US secured the third position with eight new facilities.The new registrations included 15 API facilities, 13 CMO facilities, 12 FDF facilities, and one facility engaged in both API and FDF activities. Chinese companies dominated the new FDF registrations with six facilities: Chengdu Shuode Pharma, Chengdu Suncadia Medicine, Cipla (Jiangsu), GE Healthcare (Shanghai), Luoxin Aurovitas Pharma (Chengdu), and Zhejiang Xianju Pharma.India added two new FDF facilities through Eugia Steriles and Zydus Pharma. Malaysia registered two FDF facilities through Novugen Pharma and Novugen Oncology, while Turkey’s Insud Pharma subsidiary Exeltis and US’ RK Pharma registered one FDF facility each.The 13 new CMO facilities included, Acme Generics, Emcure, Esjay Pharma, Fordoz Pharma, Fourrts Laboratories, Laboratoires KABS, PharmaMax, Quality Packaging Specialists International, Ritsa Pharma, Shanghai Aucyun Pharma, Sichuan Huiyu Pharma, Taejoon Pharm, and Tubilux Pharma.In the API category, the 15 new registrations included Acharya Chemicals, Hainan Poly Pharma, CBL Patras, EUROAPI, Hybio Pharma, Medilux Laboratories, Metrochem API, Purolite, Chengdu Easton Biopharma, Sionc Pharma, Smithfield Bioscience, Xttrium Laboratories, Zhejiang Hengkang Pharma, Moehs Iberica and Shilpa Pharma. Armstrong Pharmaceuticals registered the sole facility for both APIs and FDFs.So far, 92 facilities have not renewed their registration. Among these was a facility owned by Sandoz subsidiary Eon Labs in Wilson, North Carolina (US), which is permanently closed. In fact, the geographical distribution of non-renewals shows that 30 facilities were from the US, while India and China accounted for 14 and nine non-renewals respectively. Generic Drug Facilities Registered with the US FDA for FY2025 (Free Excel Available) Our viewThe FY 2025 GDUFA facility registration data indicates a continued strong presence of Indian manufacturers in the US generic drug market, particularly in API production. However, China's leadership in new facility registrations, especially in FDF manufacturing, suggests that the global generic drug supply chain landscape may evolve considerably in the coming years. 
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 752

    https://www.pharmacompass.com/radio-compass-blog/chinese-fda-registered-generic-facilities-gain-steam-india-maintains-lead-with-396-facilities

    #PharmaFlow by PHARMACOMPASS
    21 Nov 2024
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    Pfizer tabs controversial Chinese firm Huahai to make Paxlovid
    Pfizer tabs controversial Chinese firm Huahai to make Paxlovid

    24 Aug 2022

    // Kevin Dunleavy FIERCEPHARMA

    https://www.fiercepharma.com/manufacturing/paxlovid-production-pfizer-partners-chinese-company-huahai-which-coming-fda-ban

    Kevin Dunleavy FIERCEPHARMA
    24 Aug 2022
    Share Share
    Pfizer Picks China Firm Involved in Drug Recall for Covid Pill
    Pfizer Picks China Firm Involved in Drug Recall for Covid Pill

    23 Aug 2022

    // BLOOMBERG

    https://www.bnnbloomberg.ca/pfizer-picks-china-firm-involved-in-drug-recall-for-covid-pill-1.1809083

    BLOOMBERG
    23 Aug 2022
    Share Share
    Biocon-Viatris, AstraZeneca, Huhai and more—Fierce Pharma Asia
    Biocon-Viatris, AstraZeneca, Huhai and more—Fierce Pharma Asia

    19 Nov 2021

    // Angus Liu FIERCEPHARMA

    https://www.fiercepharma.com/pharma-asia/biocon-viatris-insulin-biosimilar-astrazeneca-china-performance-huahai-fda-warning-lift

    Angus Liu FIERCEPHARMA
    19 Nov 2021
    Share Share
    Valsartan recall protagonist comes off FDA warning letter
    Valsartan recall protagonist comes off FDA warning letter

    16 Nov 2021

    // Angus Liu FIERCEPHARMA

    https://www.fiercepharma.com/manufacturing/3-years-valsartan-recall-zhejiang-huahai-china-drug-manufacturer-fda-warning-letter

    Angus Liu FIERCEPHARMA
    16 Nov 2021
    Share Share
    Zhejiang Huahai Pharma Receives FDA Warning Letter
    Zhejiang Huahai Pharma Receives FDA Warning Letter

    11 Nov 2021

    // FDA

    https://www.pharmacompass.com/pdf/news/zhejiang-huahai-pharma-receives-fda-warning-letter-1637048144.pdf

    FDA
    11 Nov 2021
    Share Share
    EMA, FDA begin reviewing heartburn medicines for carcinogen
    EMA, FDA begin reviewing heartburn medicines for carcinogen

    17 Sep 2019

    // Zachary Brennan ENDPTS

    https://endpts.com/ema-fda-begin-reviewing-heartburn-medicines-for-carcinogen/

    Zachary Brennan ENDPTS
    17 Sep 2019
    Share Share

    ALL APIs

    read-moreClick the button for full data set
    read-moreClick the button for full data set

    01

    Candesartan Cilexetil

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    American Pharma Summit
    Not Confirmed
    arrow

    Candesartan Cilexetil

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    American Pharma Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down Click Us! arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-12-05

    Pay. Date : 2012-11-23

    DMF Number : 25455

    Submission : 2011-10-21

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2011-309 - Rev 05

    Issue Date : 2024-09-09

    Type : Chemical

    Substance Number : 2573

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 304MF10122

    Registrant's Address : Xunqiao, Linhai, Zhejiang 317024, China

    Initial Date of Registration : 2022-08-17

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 64220-114

    Start Marketing Date : 2011-02-09

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Pharmapia Co., Ltd.

    Registration Date : 2024-07-25

    Registration Number : 20200528-209-J-639(3)

    Manufacturer Name : Zhejiang Huahai Pharmaceutical Co., Ltd. Ltd

    Manufacturer Address : Xunqiao, Linhai, Zhejiang, 317024, China

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Captopril

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    American Pharma Summit
    Not Confirmed
    arrow

    Captopril

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    American Pharma Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2015-07-10

    Pay. Date : 2014-11-18

    DMF Number : 14311

    Submission : 1999-07-22

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 1997-023 - Rev 10

    Issue Date : 2020-10-19

    Type : Chemical

    Substance Number : 1079

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 227MF10237

    Registrant's Address : Xunqiao, Linhai, Zhejiang 317024, China

    Initial Date of Registration : 2015-09-24

    Latest Date of Registration :

    EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Enalapril Maleate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    American Pharma Summit
    Not Confirmed
    arrow

    Enalapril Maleate

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    American Pharma Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2018-12-11

    Pay. Date : 2018-12-04

    DMF Number : 14355

    Submission : 1999-06-22

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2000-053 - Rev 07

    Issue Date : 2023-11-23

    Type : Chemical

    Substance Number : 1420

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 227MF10268

    Registrant's Address : Xunqiao, Linhai, Zhejiang 317024, China

    Initial Date of Registration : 2015-11-19

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 64220-143

    Start Marketing Date : 2008-06-30

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Pharmapia Co., Ltd.

    Registration Date : 2024-07-25

    Registration Number : 20050831-12-B-51-08(4)

    Manufacturer Name : Zhejiang Huahai Pharmaceutical Co., Ltd.

    Manufacturer Address : Lizhuang, Xunqiao, Linhai, 317024, Zhejiang, China

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Escitalopram Oxalate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    American Pharma Summit
    Not Confirmed
    arrow

    Escitalopram Oxalate

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    American Pharma Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2014-06-17

    Pay. Date : 2013-05-03

    DMF Number : 20081

    Submission : 2006-10-17

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2016-178 - Rev 01

    Issue Date : 2024-02-23

    Type : Chemical

    Substance Number : 2733

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 303MF10128

    Registrant's Address : Xunqiao, Linhai, Zhejiang 317024, China

    Initial Date of Registration : 2021-08-16

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 64220-109

    Start Marketing Date : 2011-02-09

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Pharmapia Co., Ltd.

    Registration Date : 2024-04-09

    Registration Number : 20200221-209-J-422(3)

    Manufacturer Name : Zhejiang Huahai Pharmaceutical Co., Ltd.

    Manufacturer Address : Xunqiao, Linhai, Zhejiang, 317024, China

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Levetiracetam

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    American Pharma Summit
    Not Confirmed
    arrow

    Levetiracetam

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    American Pharma Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-05-21

    Pay. Date : 2013-05-14

    DMF Number : 23853

    Submission : 2010-06-02

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2022-399 - Rev 01

    Issue Date : 2024-08-19

    Type : Chemical

    Substance Number : 2535

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 301MF10091

    Registrant's Address : Xunqiao, Linhai, Zhejiang 317024, China

    Initial Date of Registration : 2019-11-15

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 64220-152

    Start Marketing Date : 2011-02-09

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Kukjeon Pharmaceutical Co., Ltd.

    Registration Date : 2012-10-12

    Registration Number : 20121012-183-I-139-08

    Manufacturer Name : Zhejiang Huahai Pharmaceutical Co., Ltd.

    Manufacturer Address : Chuannan, Duqiao, Linhai, Zhejiang, China

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Lisinopril

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    American Pharma Summit
    Not Confirmed
    arrow

    Lisinopril

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    American Pharma Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-03-28

    Pay. Date : 2013-03-19

    DMF Number : 14801

    Submission : 2000-03-24

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2022-237 - Rev 02

    Issue Date : 2024-07-24

    Type : Chemical

    Substance Number : 1120

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 219MF10148

    Registrant's Address : Xunqiao, Linhai, Zhejiang 317024, China

    Initial Date of Registration : 2007-04-27

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 64220-142

    Start Marketing Date : 2010-09-01

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Nevirapine

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    American Pharma Summit
    Not Confirmed
    arrow

    Nevirapine

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    American Pharma Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-01-08

    Pay. Date : 2012-12-07

    DMF Number : 19712

    Submission : 2006-08-11

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2011-223 - Rev 01

    Issue Date : 2021-07-06

    Type : Chemical

    Substance Number : 2255

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 227MF10149

    Registrant's Address : Xunqiao, Linhai, Zhejiang 317024, China

    Initial Date of Registration : 2015-05-26

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 64220-102

    Start Marketing Date : 2006-01-01

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Voriconazole

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    American Pharma Summit
    Not Confirmed
    arrow

    Voriconazole

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    American Pharma Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2014-06-23

    Pay. Date : 2013-09-03

    DMF Number : 25707

    Submission : 2011-12-20

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2011-365 - Rev 01

    Issue Date : 2020-10-20

    Type : Chemical

    Substance Number : 2576

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 306MF10092

    Registrant's Address : Xunqiao, Linhai, Zhejiang 317024, China

    Initial Date of Registration : 2024-07-03

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 64220-140

    Start Marketing Date : 2006-01-01

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Irbesartan

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    American Pharma Summit
    Not Confirmed
    arrow

    Irbesartan

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    American Pharma Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 21754

    Submission : 2008-06-27

    Status : Inactive

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2010-033 - Rev 03

    Issue Date : 2021-05-05

    Type : Chemical

    Substance Number : 2465

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 228MF10003

    Registrant's Address : Xunqiao, Linhai, Zhejiang 317024, China

    Initial Date of Registration : 2016-01-08

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 64220-130

    Start Marketing Date : 2011-02-09

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Pharmapia Co., Ltd.

    Registration Date : 2024-07-25

    Registration Number : 20110110-133-H-52-05(3)

    Manufacturer Name : Zhejiang Huahai Pharmaceutical Co., Ltd.

    Manufacturer Address : Chuannan, Duqiao, Linhai, Zhejiang 317016, China

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Losartan Potassium

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    American Pharma Summit
    Not Confirmed
    arrow

    Losartan Potassium

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    American Pharma Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 22073

    Submission : 2008-08-05

    Status : Active

    Type : II

     CEP/COS Inactive-api
    ✖

    Certificate Number : R1-CEP 2009-296 - Rev 01

    Issue Date : 2019-04-26

    Type : Chemical

    Substance Number : 2232

    Status : Withdrawn by Holder

     JDMF arrow-down
    ✖

    Registration Number : 224MF10164

    Registrant's Address : Xunqiao, Linhai, Zhejiang 317024, China

    Initial Date of Registration : 2012-08-16

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 64220-164

    Start Marketing Date : 2017-03-22

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Toru Corporation

    Registration Date : 2022-05-11

    Registration Number : 20100226-122-G-72-17(11)

    Manufacturer Name : Zhejiang Huahai Pharmaceutical Co., Ltd.

    Manufacturer Address : Chuannan, Duqiao, Linhai, Zhejiang, China

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    USDMF

    read-more
    read-more

    01

    (3s,4r) Alcohol Compound

    China
    American Pharma Summit
    Not Confirmed
    arrow

    02

    Ambrisentan

    China
    American Pharma Summit
    Not Confirmed
    arrow

    03

    Amlodipine Besylate Usp

    China
    American Pharma Summit
    Not Confirmed
    arrow

    04

    Apixaban

    China
    American Pharma Summit
    Not Confirmed
    arrow

    05

    Apremilast

    China
    American Pharma Summit
    Not Confirmed
    arrow

    06

    Aripiprazole Usp

    China
    American Pharma Summit
    Not Confirmed
    arrow

    07

    Azelaic Acid

    China
    American Pharma Summit
    Not Confirmed
    arrow

    08

    Benazepril Hydrochloride Usp

    China
    American Pharma Summit
    Not Confirmed
    arrow

    09

    Brexpiprazole

    China
    American Pharma Summit
    Not Confirmed
    arrow

    10

    Brivaracetam

    China
    American Pharma Summit
    Not Confirmed
    arrow
    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    CEP/COS

    read-more
    read-more

    01

    Amisulpride

    CEP/COS

    American Pharma Summit
    Not Confirmed
    arrow

    02

    Amlodipine besilate

    CEP/COS

    American Pharma Summit
    Not Confirmed
    arrow

    03

    Aripiprazole

    CEP/COS

    American Pharma Summit
    Not Confirmed
    arrow

    04

    Benazepril hydrochloride

    CEP/COS

    American Pharma Summit
    Not Confirmed
    arrow

    05

    Benserazide hydrochloride

    CEP/COS

    American Pharma Summit
    Not Confirmed
    arrow

    06

    Candesartan cilexetil, Sieving and non-s...

    CEP/COS

    American Pharma Summit
    Not Confirmed
    arrow

    07

    Captopril

    CEP/COS

    American Pharma Summit
    Not Confirmed
    arrow

    08

    Carvedilol

    CEP/COS

    American Pharma Summit
    Not Confirmed
    arrow

    09

    Citalopram hydrobromide

    CEP/COS

    American Pharma Summit
    Not Confirmed
    arrow

    10

    Clofazimine

    CEP/COS

    American Pharma Summit
    Not Confirmed
    arrow
    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    JDMF

    read-more
    read-more

    01

    "Japan-station" ketotifen fumarate (prod...

    JDMF

    euroPLX 86 Munich
    Not Confirmed
    arrow

    02

    Candesartan Cilexetil

    JDMF

    euroPLX 86 Munich
    Not Confirmed
    arrow

    Candesartan Cilexetil

    China
    arrow
    euroPLX 86 Munich
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Zhejiang Huahai Pharmaceutical

    Registration Number : 304MF10122

    Registrant's Address : Xunqiao, Linhai, Zhejiang 317024, China

    Initial Date of Registration : 2022-08-17

    Latest Date of Registration : 2022-08-17

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Captopril

    JDMF

    euroPLX 86 Munich
    Not Confirmed
    arrow

    Captopril

    China
    arrow
    euroPLX 86 Munich
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Zhejiang Huahai Pharmaceutical

    Registration Number : 227MF10237

    Registrant's Address : Xunqiao, Linhai, Zhejiang 317024, China

    Initial Date of Registration : 2015-09-24

    Latest Date of Registration : 2018-03-30

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Enalapril maleate

    JDMF

    euroPLX 86 Munich
    Not Confirmed
    arrow

    Enalapril maleate

    China
    arrow
    euroPLX 86 Munich
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Zhejiang Huahai Pharmaceutical

    Registration Number : 227MF10268

    Registrant's Address : Xunqiao, Linhai, Zhejiang 317024, China

    Initial Date of Registration : 2015-11-19

    Latest Date of Registration : 2021-04-19

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Escitalopram Oxalate

    JDMF

    euroPLX 86 Munich
    Not Confirmed
    arrow

    Escitalopram Oxalate

    China
    arrow
    euroPLX 86 Munich
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Zhejiang Huahai Pharmaceutical

    Registration Number : 303MF10128

    Registrant's Address : Xunqiao, Linhai, Zhejiang 317024, China

    Initial Date of Registration : 2021-08-16

    Latest Date of Registration : 2021-08-16

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Irbesartan

    JDMF

    euroPLX 86 Munich
    Not Confirmed
    arrow

    Irbesartan

    China
    arrow
    euroPLX 86 Munich
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Zhejiang Huahai Pharmaceutical

    Registration Number : 228MF10003

    Registrant's Address : Xunqiao, Linhai, Zhejiang 317024, China

    Initial Date of Registration : 2016-01-08

    Latest Date of Registration : 2016-01-08

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Levetiracetam

    JDMF

    euroPLX 86 Munich
    Not Confirmed
    arrow

    Levetiracetam

    China
    arrow
    euroPLX 86 Munich
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Zhejiang Huahai Pharmaceutical

    Registration Number : 306MF10094

    Registrant's Address : Xunqiao, Linhai, Zhejiang 317024, China

    Initial Date of Registration : 2024-07-11

    Latest Date of Registration : 2024-07-11

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Levetiracetam

    JDMF

    euroPLX 86 Munich
    Not Confirmed
    arrow

    Levetiracetam

    China
    arrow
    euroPLX 86 Munich
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Zhejiang Huahai Pharmaceutical

    Registration Number : 301MF10091

    Registrant's Address : Xunqiao, Linhai, Zhejiang 317024, China

    Initial Date of Registration : 2019-11-15

    Latest Date of Registration : 2019-11-15

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Lisinopril hydrate

    JDMF

    euroPLX 86 Munich
    Not Confirmed
    arrow

    Lisinopril hydrate

    China
    arrow
    euroPLX 86 Munich
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Zhejiang Huahai Pharmaceutical

    Registration Number : 219MF10148

    Registrant's Address : Xunqiao, Linhai, Zhejiang 317024, China

    Initial Date of Registration : 2007-04-27

    Latest Date of Registration : 2019-05-21

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Losartan potassium

    JDMF

    euroPLX 86 Munich
    Not Confirmed
    arrow

    Losartan potassium

    China
    arrow
    euroPLX 86 Munich
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Zhejiang Huahai Pharmaceutical

    Registration Number : 224MF10164

    Registrant's Address : Xunqiao, Linhai, Zhejiang 317024, China

    Initial Date of Registration : 2012-08-16

    Latest Date of Registration : 2012-08-16

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    KDMF

    read-more
    read-more

    01

    Aripiprazole

    China
    euroPLX 86 Munich
    Not Confirmed
    arrow

    Aripiprazole

    China
    arrow
    euroPLX 86 Munich
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Zhejiang Huahai Pharmaceutical

    Registrant Name : Youngjin Pharmaceutical Co., Ltd.

    Registration Date : 2021-12-30

    Registration Number : 20210416-209-J-941(2)

    Manufacturer Name : Zhejiang Huahai Pharmaceutical...

    Manufacturer Address : Xunqiao, Linhai, Zhejiang, 317024, China.)

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    02

    Aripiprazole

    China
    euroPLX 86 Munich
    Not Confirmed
    arrow

    Aripiprazole

    China
    arrow
    euroPLX 86 Munich
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Zhejiang Huahai Pharmaceutical

    Registrant Name : Lihu Healthcare Co., Ltd.

    Registration Date : 2021-04-16

    Registration Number : 20210416-209-J-941

    Manufacturer Name : Zhejiang Huahai Pharmaceutical...

    Manufacturer Address : Xunqiao, Linhai, Zhejiang 317024, China

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    03

    Aripiprazole

    China
    euroPLX 86 Munich
    Not Confirmed
    arrow

    Aripiprazole

    China
    arrow
    euroPLX 86 Munich
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Zhejiang Huahai Pharmaceutical

    Registrant Name : Kukjeon Pharmaceutical Co., Ltd.

    Registration Date : 2021-06-26

    Registration Number : 20210416-209-J-941(1)

    Manufacturer Name : Zhejiang Huahai Pharmaceutical...

    Manufacturer Address : Xunqiao, Linhai, Zhejiang 317024, China

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    04

    Benserazide hydrochloride

    China
    euroPLX 86 Munich
    Not Confirmed
    arrow

    Benserazide hydrochloride

    China
    arrow
    euroPLX 86 Munich
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Zhejiang Huahai Pharmaceutical

    Registrant Name : Kukjeon Pharmaceutical Co., Ltd.

    Registration Date : 2023-05-26

    Registration Number : 20230526-211-J-1499

    Manufacturer Name : Zhejiang Huahai Pharmaceutical...

    Manufacturer Address : Chuannan Duqiao, Linhai, Zhejiang, 317016, China.

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    05

    Brivaracetam

    China
    euroPLX 86 Munich
    Not Confirmed
    arrow

    Brivaracetam

    China
    arrow
    euroPLX 86 Munich
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Zhejiang Huahai Pharmaceutical

    Registrant Name : Samoh Pharmaceutical Co., Ltd.

    Registration Date : 2024-07-25

    Registration Number : Number 207-66-ND

    Manufacturer Name : Zhejiang Huahai Pharmaceutical...

    Manufacturer Address : Chuannan, Duqiao, Linhai, Zhejiang, 317016, China.

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    06

    Candesartan cilexetil

    China
    euroPLX 86 Munich
    Not Confirmed
    arrow

    Candesartan cilexetil

    China
    arrow
    euroPLX 86 Munich
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Zhejiang Huahai Pharmaceutical

    Registrant Name : Pharmapia Co., Ltd.

    Registration Date : 2024-07-25

    Registration Number : 20200528-209-J-639(3)

    Manufacturer Name : Zhejiang Huahai Pharmaceutical...

    Manufacturer Address : Xunqiao, Linhai, Zhejiang, 317024, China

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    07

    Candesartan cilexetil

    China
    euroPLX 86 Munich
    Not Confirmed
    arrow

    Candesartan cilexetil

    China
    arrow
    euroPLX 86 Munich
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Zhejiang Huahai Pharmaceutical

    Registrant Name : Myungmoon Pharmaceutical Co., Ltd.

    Registration Date : 2021-07-01

    Registration Number : 20200528-209-J-639(2)

    Manufacturer Name : Zhejiang Huahai Pharmaceutical...

    Manufacturer Address : Xunqiao, Linhai, Zhejiang, 317024, China.

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    08

    Candesartan cilexetil

    China
    euroPLX 86 Munich
    Not Confirmed
    arrow

    Candesartan cilexetil

    China
    arrow
    euroPLX 86 Munich
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Zhejiang Huahai Pharmaceutical

    Registrant Name : SG Biochem Co., Ltd.

    Registration Date : 2021-06-24

    Registration Number : 20200528-209-J-639(1)

    Manufacturer Name : Zhejiang Huahai Pharmaceutical...

    Manufacturer Address : Xunqiao, Linhai, Zhejiang, 317024, China.

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    09

    Candesartan cilexetil

    China
    euroPLX 86 Munich
    Not Confirmed
    arrow

    Candesartan cilexetil

    China
    arrow
    euroPLX 86 Munich
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Zhejiang Huahai Pharmaceutical

    Registrant Name : Lihu Healthcare Co., Ltd.

    Registration Date : 2020-05-28

    Registration Number : 20200528-209-J-639

    Manufacturer Name : Zhejiang Huahai Pharmaceutical...

    Manufacturer Address : Xunqiao, Linhai, Zhejiang, 317024, China

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    10

    Carvedilol

    China
    euroPLX 86 Munich
    Not Confirmed
    arrow

    Carvedilol

    China
    arrow
    euroPLX 86 Munich
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Zhejiang Huahai Pharmaceutical

    Registrant Name : Lihu Healthcare Co., Ltd.

    Registration Date : 2013-03-08

    Registration Number : 20130308-60-B-357-26

    Manufacturer Name : Zhejiang Huahai Pharmaceutical...

    Manufacturer Address : Xunqiao, Linhai, 317024, Zhejiang, China

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    NDC API

    read-more
    read-more

    01

    2,3-DIAMINOPROPIONIC ACID HYDROCHLORIDE, (-)-

    China
    euroPLX 86 Munich
    Not Confirmed
    arrow

    02

    03

    AGOMELATINE

    China
    euroPLX 86 Munich
    Not Confirmed
    arrow

    AGOMELATINE

    China
    arrow
    euroPLX 86 Munich
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Zhejiang Huahai Pharmaceutical

    NDC Package Code : 64220-223

    Start Marketing Date : 2024-07-30

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    AMLODIPINE BESYLATE

    China
    euroPLX 86 Munich
    Not Confirmed
    arrow

    AMLODIPINE BESYLATE

    China
    arrow
    euroPLX 86 Munich
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Zhejiang Huahai Pharmaceutical

    NDC Package Code : 64220-183

    Start Marketing Date : 2021-05-01

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    APIXABAN

    China
    American Pharma Summit
    Not Confirmed
    arrow

    APIXABAN

    China
    arrow
    American Pharma Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Zhejiang Huahai Pharmaceutical

    NDC Package Code : 64220-185

    Start Marketing Date : 2024-04-12

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    APREMILAST

    China
    euroPLX 86 Munich
    Not Confirmed
    arrow

    APREMILAST

    China
    arrow
    euroPLX 86 Munich
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Zhejiang Huahai Pharmaceutical

    NDC Package Code : 64220-200

    Start Marketing Date : 2024-08-14

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    ARIPIPRAZOLE

    China
    euroPLX 86 Munich
    Not Confirmed
    arrow

    ARIPIPRAZOLE

    China
    arrow
    euroPLX 86 Munich
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Zhejiang Huahai Pharmaceutical

    NDC Package Code : 64220-112

    Start Marketing Date : 2011-02-09

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    AZELAIC ACID

    China
    euroPLX 86 Munich
    Not Confirmed
    arrow

    AZELAIC ACID

    China
    arrow
    euroPLX 86 Munich
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Zhejiang Huahai Pharmaceutical

    NDC Package Code : 64220-204

    Start Marketing Date : 2023-08-01

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    BENAZEPRIL HYDROCHLORIDE

    China
    euroPLX 86 Munich
    Not Confirmed
    arrow

    BENAZEPRIL HYDROCHLORIDE

    China
    arrow
    euroPLX 86 Munich
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Zhejiang Huahai Pharmaceutical

    NDC Package Code : 64220-145

    Start Marketing Date : 2005-12-01

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    BREXPIPRAZOLE

    China
    euroPLX 86 Munich
    Not Confirmed
    arrow

    BREXPIPRAZOLE

    China
    arrow
    euroPLX 86 Munich
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Zhejiang Huahai Pharmaceutical

    NDC Package Code : 64220-205

    Start Marketing Date : 2024-08-19

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view

    LISTED APIs

    read-more
    read-more
    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ambrisentan

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and...
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.
    blank

    01

    Ambrisentan

    China
    BioFlorida Conference
    Not Confirmed
    arrow

    Ambrisentan

    China
    arrow
    BioFlorida Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Zhejiang Huahai Pharmaceutical

    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.

    About the Company : Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a larg...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Aripiprazole

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and...
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.
    blank

    02

    Aripiprazole

    China
    BioFlorida Conference
    Not Confirmed
    arrow

    Aripiprazole

    China
    arrow
    BioFlorida Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Zhejiang Huahai Pharmaceutical

    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.

    About the Company : Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a larg...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Benazepril Hydrochloride

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and...
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.
    blank

    03

    Benazepril Hydrochloride

    China
    BioFlorida Conference
    Not Confirmed
    arrow

    Benazepril Hydrochloride

    China
    arrow
    BioFlorida Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Zhejiang Huahai Pharmaceutical

    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.

    About the Company : Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a larg...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Candesartan Cilexetil

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and...
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.
    blank

    04

    Candesartan Cilexetil

    China
    BioFlorida Conference
    Not Confirmed
    arrow

    Candesartan Cilexetil

    China
    arrow
    BioFlorida Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Zhejiang Huahai Pharmaceutical

    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.

    About the Company : Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a larg...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Captopril

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and...
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.
    blank

    05

    Captopril

    China
    BioFlorida Conference
    Not Confirmed
    arrow

    Captopril

    China
    arrow
    BioFlorida Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Zhejiang Huahai Pharmaceutical

    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.

    About the Company : Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a larg...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Carvedilol

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and...
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.
    blank

    06

    Carvedilol

    China
    BioFlorida Conference
    Not Confirmed
    arrow

    Carvedilol

    China
    arrow
    BioFlorida Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Zhejiang Huahai Pharmaceutical

    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.

    About the Company : Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a larg...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Citalopram Hydrobromide

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and...
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.
    blank

    07

    Citalopram Hydrobromide

    China
    BioFlorida Conference
    Not Confirmed
    arrow

    Citalopram Hydrobromide

    China
    arrow
    BioFlorida Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Zhejiang Huahai Pharmaceutical

    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.

    About the Company : Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a larg...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Donepezil Hydrochloride

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and...
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.
    blank

    08

    Donepezil Hydrochloride

    China
    BioFlorida Conference
    Not Confirmed
    arrow

    Donepezil Hydrochloride

    China
    arrow
    BioFlorida Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Zhejiang Huahai Pharmaceutical

    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.

    About the Company : Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a larg...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    duloxetine hydrochloride

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and...
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.
    blank

    09

    duloxetine hydrochloride

    China
    BioFlorida Conference
    Not Confirmed
    arrow

    duloxetine hydrochloride

    China
    arrow
    BioFlorida Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Zhejiang Huahai Pharmaceutical

    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.

    About the Company : Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a larg...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Enalapril Maleate

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and...
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.
    blank

    10

    Enalapril Maleate

    China
    BioFlorida Conference
    Not Confirmed
    arrow

    Enalapril Maleate

    China
    arrow
    BioFlorida Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Zhejiang Huahai Pharmaceutical

    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.

    About the Company : Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a larg...

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    ALL Intermediates

    read-more
    read-more
    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    (3s)-3-amino-1-t-butoxycarbonylmethyl-2,3,4,5-tetrahydro-1H-be...

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    109010-60-8
    Benazepril
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was ...
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.
    blank

    01

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    N-[1-[(S)-ethoxycarbonyl-3-phenylpropyl]-L-alanine

    Intermediate Web Link

    Market Place

    82717-96-2
    Enalapril Maleate
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was ...
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.
    blank

    02

    N-[1-[(S)-ethoxycarbonyl-3-phenylpropyl]-L-alanine

    China
    Pharma Manufacturing 2024
    Not Confirmed
    arrow
    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    N-[1-(S)-ethoxycarbonyl-3-phenylpropyl]-L-alanine N-carboxyanh...

    Intermediate Web Link

    Market Place

    84793-24-8
    Enalapril Maleate
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was ...
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.
    blank

    03

    N-[1-(S)-ethoxycarbonyl-3-phenylpropyl]-L-alanine N-carboxyanhydride

    China
    Pharma Manufacturing 2024
    Not Confirmed
    arrow
    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    [(2-methyl-1-propionylpropoxy)(4-phenylbutyl)phosphinoyl]aceti...

    Intermediate Web Link

    Market Place

    137590-32-0
    Fosinopril
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was ...
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.
    blank

    04

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    trans-4-Cyclohexyl-L-proline,hychochloride

    Intermediate Web Link

    Market Place

    90657-55-9
    Fosinopril
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was ...
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.
    blank

    05

    trans-4-Cyclohexyl-L-proline,hychochloride

    China
    Pharma Manufacturing 2024
    Not Confirmed
    arrow

    trans-4-Cyclohexyl-L-proline,hychochloride

    China
    Pharma Manufacturing 2024
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Zhejiang Huahai Pharmaceutical

    trans-4-Cyclohexyl-L-proline,hychochloride

    CAS Number : 90657-55-9

    End Use API : Fosinopril

    About the Company : Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed ...

    blank

    Intermediate Web Link

    Market Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    trans-4-Cyclohexyl-L-proline

    Intermediate Web Link

    Market Place

    103201-78-1
    Fosinopril
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was ...
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.
    blank

    06

    trans-4-Cyclohexyl-L-proline

    China
    Pharma Manufacturing 2024
    Not Confirmed
    arrow

    trans-4-Cyclohexyl-L-proline

    China
    Pharma Manufacturing 2024
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Zhejiang Huahai Pharmaceutical

    trans-4-Cyclohexyl-L-proline

    CAS Number : 103201-78-1

    End Use API : Fosinopril

    About the Company : Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed ...

    blank

    Intermediate Web Link

    Market Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    (S)-1,2,3,4,-Tetrahydro-3-isoquinolinecarboxylic Acid, benzyl ...

    Intermediate Web Link

    Market Place

    77497-97-3
    Quinapril
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was ...
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.
    blank

    07

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    (S)-1,2,3,4,-Tetrahydro-3-isoquinolinecarboxylic acid

    Intermediate Web Link

    Market Place

    74163-81-8
    Quinapril
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was ...
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.
    blank

    08

    (S)-1,2,3,4,-Tetrahydro-3-isoquinolinecarboxylic acid

    China
    Pharma Manufacturing 2024
    Not Confirmed
    arrow
    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Endo,cis-2-azabicyclo[3,3,0]octane-3-carboxylic acid benzyl es...

    Intermediate Web Link

    Market Place

    93779-29-4
    Ramipril
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was ...
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.
    blank

    09

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    N2-[(1s)-ethoxycarbonyl-3-phenylpropyl]-N6-trifluoroacetyl-L-l...

    Intermediate Web Link

    Market Place

    103300-91-0
    Lisinopril
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was ...
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.
    blank

    10

    N2-[(1s)-ethoxycarbonyl-3-phenylpropyl]-N6-trifluoroacetyl-L-lysine

    China
    Pharma Manufacturing 2024
    Not Confirmed
    arrow
    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Inspections and registrations

    Upload your audits for free, ask us

    FDA

    read-more
    read-more

    01

    FDA Audited

    USA
    BioFlorida Conference
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    BioFlorida Conference
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2010-09-02

    Zhejiang Huahai Pharmaceutical

    City : Linhai,

    State :

    Country/Area : CN

    Zip :

    District : ORA

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2010-09-02

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    02

    FDA Audited

    USA
    BioFlorida Conference
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    BioFlorida Conference
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2010-09-08

    Zhejiang Huahai Pharmaceutical

    City : Duqiao, Linhai City

    State :

    Country/Area : CN

    Zip :

    District : ORA

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2010-09-08

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    03

    FDA Audited

    USA
    BioFlorida Conference
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    BioFlorida Conference
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2013-08-09

    Zhejiang Huahai Pharmaceutical

    City : Linhai,

    State :

    Country/Area : CN

    Zip :

    District : ORA

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2013-08-09

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    04

    FDA Audited

    USA
    BioFlorida Conference
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    BioFlorida Conference
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2014-05-23

    Zhejiang Huahai Pharmaceutical

    City : Duqiao, Linhai City

    State :

    Country/Area : CN

    Zip :

    District : ORA

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2014-05-23

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    05

    FDA Audited

    USA
    BioFlorida Conference
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    BioFlorida Conference
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2015-03-27

    Zhejiang Huahai Pharmaceutical

    City : Linhai,

    State :

    Country/Area : CN

    Zip :

    District : ORA

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2015-03-27

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    06

    FDA Audited

    USA
    BioFlorida Conference
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    BioFlorida Conference
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2017-05-19

    Zhejiang Huahai Pharmaceutical

    City : Duqiao

    State :

    Country/Area : CN

    Zip :

    District : ORA

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2017-05-19

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    EDQM

    read-more
    read-more

    01

    GMP Certified

    EU
    Pharma Manufacturing 2024
    Not Confirmed
    arrow

    GMP Certified

    EU
    arrow
    Pharma Manufacturing 2024
    Not Confirmed

    Zhejiang Huahai Pharmaceutical

    Type : GMP Certificates

    Number : 2007/HMP/PT...

    EudraGMDP Key : 8767

    Country : China

    Issue Date :

    Post Code : 317024

    NCA Ref : A058 3020 84...

    City : LINHAI, PROVINCE ZHEJIA...

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    02

    GMP Certified

    EU
    Pharma Manufacturing 2024
    Not Confirmed
    arrow

    GMP Certified

    EU
    arrow
    Pharma Manufacturing 2024
    Not Confirmed

    Zhejiang Huahai Pharmaceutical

    Type : GMP Certificates

    Number : ES/137/11

    EudraGMDP Key : 11558

    Country : China

    Issue Date :

    Post Code : 317024

    NCA Ref : 405

    City : Zhejiang China

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    03

    GMP Certified

    EU
    Pharma Manufacturing 2024
    Not Confirmed
    arrow

    GMP Certified

    EU
    arrow
    Pharma Manufacturing 2024
    Not Confirmed

    Zhejiang Huahai Pharmaceutical

    Type : GMP Certificates

    Number : ES/123/11

    EudraGMDP Key : 11560

    Country : China

    Issue Date :

    Post Code : 317024

    NCA Ref : 404

    City : Zhejiang China

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    04

    GMP Certified

    EU
    Pharma Manufacturing 2024
    Not Confirmed
    arrow

    GMP Certified

    EU
    arrow
    Pharma Manufacturing 2024
    Not Confirmed

    Zhejiang Huahai Pharmaceutical

    Type : GMP Certificates

    Number : ES/033/12

    EudraGMDP Key : 11560

    Country : China

    Issue Date :

    Post Code : 317024

    NCA Ref : 404

    City : Zhejiang China

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    05

    GMP Certified

    EU
    Pharma Manufacturing 2024
    Not Confirmed
    arrow

    GMP Certified

    EU
    arrow
    Pharma Manufacturing 2024
    Not Confirmed

    Zhejiang Huahai Pharmaceutical

    Type : GMP Certificates

    Number : ES/029/12

    EudraGMDP Key : 11560

    Country : China

    Issue Date :

    Post Code : 317024

    NCA Ref : 404

    City : Zhejiang China

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    06

    GMP Certified

    EU
    Pharma Manufacturing 2024
    Not Confirmed
    arrow

    GMP Certified

    EU
    arrow
    Pharma Manufacturing 2024
    Not Confirmed

    Zhejiang Huahai Pharmaceutical

    Type : GMP Certificates

    Number : ES/030/12

    EudraGMDP Key : 11560

    Country : China

    Issue Date :

    Post Code : 317024

    NCA Ref : 404

    City : Zhejiang China

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    07

    GMP Certified

    EU
    Pharma Manufacturing 2024
    Not Confirmed
    arrow

    GMP Certified

    EU
    arrow
    Pharma Manufacturing 2024
    Not Confirmed

    Zhejiang Huahai Pharmaceutical

    Type : GMP Certificates

    Number : ES/031/12

    EudraGMDP Key : 11560

    Country : China

    Issue Date :

    Post Code : 317024

    NCA Ref : 404

    City : Zhejiang China

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    08

    GMP Certified

    EU
    Pharma Manufacturing 2024
    Not Confirmed
    arrow

    GMP Certified

    EU
    arrow
    Pharma Manufacturing 2024
    Not Confirmed

    Zhejiang Huahai Pharmaceutical

    Type : GMP Certificates

    Number : DE_HH_01_GM...

    EudraGMDP Key : 26737

    Country : China

    Issue Date :

    Post Code : 317016

    NCA Ref : 20742

    City : Zhejiang

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    09

    GMP Certified

    EU
    Pharma Manufacturing 2024
    Not Confirmed
    arrow

    GMP Certified

    EU
    arrow
    Pharma Manufacturing 2024
    Not Confirmed

    Zhejiang Huahai Pharmaceutical

    Type : GMP Certificates

    Number : DE_HH_01_GM...

    EudraGMDP Key : 30108

    Country : China

    Issue Date : 2016-02-04

    Post Code : 317024

    NCA Ref : 00021462

    City : Zhejiang

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    10

    GMP Certified

    EU
    Pharma Manufacturing 2024
    Not Confirmed
    arrow

    GMP Certified

    EU
    arrow
    Pharma Manufacturing 2024
    Not Confirmed

    Zhejiang Huahai Pharmaceutical

    Type : GMP Certificates

    Number : DE_HH_01_GM...

    EudraGMDP Key : 30108

    Country : China

    Issue Date : 2015-09-01

    Post Code : 317024

    NCA Ref : 00021462

    City : Zhejiang

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    ABOUT THIS PAGE

    Contact Zhejiang Huahai Pharmaceutical and get a quotation

    Zhejiang Huahai Pharmaceutical is a supplier offers 107 products (APIs, Excipients or Intermediates).

    Find a price of Candesartan Cilexetil bulk with DMF, CEP, JDMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Captopril bulk with DMF, CEP, JDMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Enalapril Maleate bulk with DMF, CEP, JDMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Escitalopram Oxalate bulk with DMF, CEP, JDMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Levetiracetam bulk with DMF, CEP, JDMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Lisinopril bulk with DMF, CEP, JDMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Nevirapine bulk with DMF, CEP, JDMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Voriconazole bulk with DMF, CEP, JDMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Irbesartan bulk with CEP, JDMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Levetiracetam bulk with CEP, JDMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Losartan Potassium bulk with DMF, JDMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Losartan Potassium bulk with CEP, JDMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Amlodipine Besylate bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical

    Find a price of Aripiprazole bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical

    Find a price of Benazepril Hydrochloride bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical

    Find a price of Carvedilol bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical

    Find a price of Citalopram Hydrobromide bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical

    Find a price of Clofazimine bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical

    Find a price of Clopidogrel bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical

    Find a price of Donepezil bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical

    Find a price of Duloxetine Hydrochloride bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical

    Find a price of Etilevodopa bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical

    Find a price of Fosinopril bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical

    Find a price of Gabapentin bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical

    Find a price of Hydrochlorothiazide bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical

    Find a price of Ketotifen Fumarate bulk with CEP, JDMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Lamotrigine bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical

    Find a price of Metoprolol Succinate bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical

    Find a price of Nebivolol bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical

    Find a price of Olmesartan Medoxomil bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical

    Find a price of Oseltamivir Phosphate bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical

    Find a price of Paroxetine Hydrochloride bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical

    Find a price of Pioglitazone Hydrochloride bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical

    Find a price of Pregabalin bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical

    Find a price of Quetiapine Hemifumarate bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical

    Find a price of Quinapril bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical

    Find a price of Ramipril bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical

    Find a price of Risperidone bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical

    Find a price of Rivaroxaban bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical

    Find a price of Rocuronium Bromide bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical

    Find a price of Ropinirole Hydrochloride bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical

    Find a price of Sitagliptin Phosphate bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical

    Find a price of Tadalafil bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical

    Find a price of Telmisartan bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical

    Find a price of Torsemide bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical

    Find a price of Valsartan bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical

    Find a price of Paroxetine Hydrochloride bulk with CEP offered by Zhejiang Huahai Pharmaceutical

    Find a price of Valsartan bulk with CEP offered by Zhejiang Huahai Pharmaceutical

    Find a price of Ambrisentan bulk with DMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Amisulpride bulk with CEP offered by Zhejiang Huahai Pharmaceutical

    Find a price of Apixaban bulk with DMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Apremilast bulk with DMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Azelaic Acid bulk with DMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Benserazide Hydrochloride bulk with CEP offered by Zhejiang Huahai Pharmaceutical

    Find a price of Brexpiprazole bulk with DMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Brivaracetam bulk with DMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Canagliflozin bulk with DMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Cariprazine Hydrochloride bulk with DMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Carvedilol Phosphate bulk with DMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Dabigatran Etexilate Mesylate bulk with DMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Dapagliflozin Propanediol Monohydrate bulk with DMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Dimethyl Fumarate bulk with DMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Edoxaban Tosylate bulk with DMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Efavirenz bulk with DMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Elagolix Sodium bulk with DMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Empagliflozin bulk with DMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Entecavir bulk with DMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Eprosartan Mesylate bulk with DMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Ethanol bulk with DMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Febuxostat bulk with DMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Fingolimod Hydrochloride bulk with DMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Gabapentin bulk with CEP offered by Zhejiang Huahai Pharmaceutical

    Find a price of Gefitinib bulk with CEP offered by Zhejiang Huahai Pharmaceutical

    Find a price of Irbesartan bulk with DMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Lacosamide bulk with CEP offered by Zhejiang Huahai Pharmaceutical

    Find a price of Levetiracetam bulk with DMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Levetiracetam bulk offered by Zhejiang Huahai Pharmaceutical

    Find a price of Linagliptin bulk with DMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Lisinopril bulk with CEP offered by Zhejiang Huahai Pharmaceutical

    Find a price of Losartan Potassium bulk with DMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Milnacipran HCl bulk with DMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Mirabegron bulk with DMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Nevirapine bulk with CEP offered by Zhejiang Huahai Pharmaceutical

    Find a price of Nicardipine Hydrochloride bulk with DMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Olmesartan Medoxomil bulk with CEP offered by Zhejiang Huahai Pharmaceutical

    Find a price of Paliperidone bulk with DMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Paroxetine Mesylate bulk with DMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Perindopril Erbumine bulk with CEP offered by Zhejiang Huahai Pharmaceutical

    Find a price of Ranolazine bulk with DMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Rivaroxaban bulk with CEP offered by Zhejiang Huahai Pharmaceutical

    Find a price of Rocuronium Bromide bulk with CEP offered by Zhejiang Huahai Pharmaceutical

    Find a price of Safinamide Mesylate bulk with DMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Silodosin bulk with DMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Telmisartan bulk with CEP offered by Zhejiang Huahai Pharmaceutical

    Find a price of Tenofovir Disoproxil Fumarate bulk with DMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Thiaproline-M-Amino Benzoic Acid Hydrochloride bulk with DMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Tofacitinib Citrate bulk with DMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Tolvaptan bulk with DMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Topiramate bulk with DMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of UNII-B7XF2TD73C bulk with DMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Vortioxetine Hydrobromide bulk with DMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of SACUBITRIL VALSARTAN SODIUM bulk with DMF offered by Zhejiang Huahai Pharmaceutical

    Find a price of Dimethyl Fumarate bulk offered by Zhejiang Huahai Pharmaceutical

    Find a price of Donepezil bulk offered by Zhejiang Huahai Pharmaceutical

    Find a price of Losartan Potassium bulk offered by Zhejiang Huahai Pharmaceutical

    Find a price of Paroxetine Hydrochloride bulk offered by Zhejiang Huahai Pharmaceutical

    Find a price of Strontium Ranelate bulk offered by Zhejiang Huahai Pharmaceutical

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search